Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease
NCT00005595
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
Unable to accrue subjects in a timely fashion.
Conditions
Lymphoma
Interventions
DRUG:
arsenic trioxide
Sponsor
Northwestern University
Collaborators
[object Object]